Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
02/2009
02/19/2009WO2008154493A3 Novel peptides that inhibit the opening of mammalian tight junctions
02/19/2009WO2008147859A3 Self-assembled proteins and related methods and protein structures
02/19/2009WO2008137681A3 Pp1 ligands
02/19/2009US20090047290 Monoclonal antibodies against beta3 integrins
02/19/2009CA2696478A1 Protein-polymer conjugates
02/18/2009EP2025345A1 KIM-1 antagonists and use to modulate immune system
02/18/2009EP2024386A2 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
02/18/2009EP2023852A2 Biomolecule-linked biomimetic scaffolds
02/17/2009US7491800 Cytokine zalpha11 ligand fusion proteins
02/17/2009US7491703 Tetrapeptide regulating blood glucose level in diabetes mellitus
02/17/2009US7491402 Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof
02/17/2009US7491397 Receptor binding polypeptides
02/17/2009US7491396 peptides; reduced allergenic activity as compared to Phl p 2 wild type; vaccine; biodrug
02/17/2009CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity
02/15/2009CA2628900A1 Monoclonal antibodies against .beta.3 integrins
02/12/2009WO2007055982A3 Therapies for the regulation of insulin and glucose using rlip76
02/12/2009US20090042768 Purine derivatives and their use for treatment of autoimmune diseases
02/12/2009US20090042733 Process for detecting or quantifying nucleic acids in a library
02/12/2009US20090042252 Interferon-alpha polypeptides and conjugates
02/12/2009US20090042235 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide
02/12/2009US20090041791 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond
02/12/2009CA2669453A1 Glucanases, nucleic acids encoding them and methods for making and using them
02/11/2009EP2021374A1 Biocompatible three dimensional matrix for the immobilization of biological substances
02/11/2009CN101365724A Immunogenic compositions and methods of use
02/10/2009US7488801 Interferon-alpha polypeptides and conjugates
02/10/2009US7488799 Prostaglandin receptor protein
02/10/2009US7488795 PRO846 polypeptides
02/10/2009US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof
02/10/2009US7488608 Receptor binding assays using reactive polysaccharide solid supports, testing for immunoglobulins, albumins, casein and gelatins; reduction of false positive results
02/10/2009US7488589 Interferon-alpha polypeptides and conjugates
02/10/2009US7488473 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide
02/05/2009CA2700000A1 Diagnostic assay for trypanosoma cruzi infection
02/04/2009CN101357945A Synthetic peptide coupling antigen and reagent for testing porcine circovurus type 2 specific antibody
02/03/2009US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease
02/03/2009US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines
02/03/2009US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions
02/03/2009CA2150925C Improved synthesis of polymer bio-active conjugates
01/2009
01/28/2009EP2019118A1 Method for synthesizing thymosins
01/28/2009CN101355956A Use of complement pathway inhibitors to treat ocular diseases
01/28/2009CN101355928A Compositions and methods for cancer immunotherapy
01/27/2009US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay
01/27/2009US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
01/27/2009US7482433 Peptides of sequence of amino acids where one or more of the peptidyl [ C(O)NR ] linkages (bonds) have been replaced by a non-peptidyl linkage; IL-5 antagonists treating asthma
01/27/2009US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases
01/27/2009CA2319206C Peptide structures and their use in diagnosis of herpes simplex virus type 2
01/21/2009EP2017287A2 Method of producing hydroxyalkyl starch derivatives
01/21/2009EP1432443B1 Angiotensin peptide-carrier conjugates and uses thereof
01/20/2009US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
01/20/2009US7479282 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
01/20/2009US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases
01/15/2009WO2008097854A4 Method and substances for treating hpv infection
01/15/2009US20090018077 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090018076 Fibroblast Growth Factor-Like Polypeptides
01/15/2009US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences
01/15/2009US20090017502 Interferon-alpha polypeptides and conjugates
01/15/2009US20090017501 Interferon-alpha polypeptides and conjugates
01/15/2009US20090017500 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide
01/15/2009US20090017030 Endothelial Cell Expression Patterns
01/14/2009EP2014772A2 Method for the diagnosis and prognosis of cancer
01/14/2009EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis
01/14/2009EP1183049B1 Modification of biological elements
01/14/2009EP0948539B1 Peptides and compounds that bind to a receptor
01/13/2009US7476523 used to pattern the inside of a tube or rolled over a surface to form a continuous pattern; may be used to deposit self-assembled monolayers, biological materials, metals, polymers, ceramics, or a variety of other materials
01/08/2009WO2009004142A2 Method for fixing compounds comprising peptide bonds, such as proteins, to a microsystem, and microsystem incorporating these compounds
01/08/2009US20090012274 Unsaturated aldehyde surfaces and methods of molecular immobilization
01/08/2009US20090011958 Process for immobilizing orientation-controlled protein and process for arraying and immobilizing protein using the same
01/08/2009US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells
01/07/2009EP1532239B1 Methods and compositions for targeting secretory lysosomes
01/07/2009EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a
01/06/2009US7473781 Zinc complex of N,N,N',N'-tetrakis[(2-pyridyl)methyl]-1,3-diamino-2-propanol bound to a polymer such as an epoxy resin or Sepharose that is capable of capturing, separating and purifying a substance having an anionic substituent, e.g., a phosphorylated protein chip
01/06/2009US7473671 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
01/01/2009US20090004670 Methods for fabricating surface enhanced fluorescent (sef) nanoparticles and their applications in bioassays
12/2008
12/31/2008WO2009000950A1 Method for the deblocking/deprotection of compounds obtained by solid phase synthesis
12/31/2008WO2009000089A1 Immunomodulatory compositions and methods for treating disease with modified host defense peptides
12/31/2008WO2009000077A1 Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
12/31/2008WO2008112891A3 Monoclonal antibody that recognizes a seneca valley virus (svv) cellular receptor and uses thereof
12/31/2008EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
12/31/2008CN100447156C T2R taste receptors and genes encoding same
12/31/2008CA2692171A1 Methods and uses thereof of prosaposin
12/30/2008US7470778 extractants employed are ionic liquids of the general formula K+A-; kits
12/30/2008US7470774 Anti-pro1477 antibodies
12/30/2008US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization
12/30/2008CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses
12/24/2008WO2008024105A3 Nanocomposites of repeat sequence proteins and phyllosilicate clays and their preparation
12/24/2008EP2004666A2 Ras mutation and compositions and methods related thereto
12/24/2008EP1181555B1 Cancer treatment with endothelin receptor antagonists
12/24/2008CA2690823A1 Matrix assisted ink transport
12/23/2008US7468427 Antibodies to PRO1275 polypeptide
12/23/2008US7468424 Antibody that binds to the protein; given amino acid sequence
12/23/2008US7468278 having pesticidal activity against insect pests, including Coleoptera
12/18/2008WO2008133433A3 Intact surface display of substances of interest
12/18/2008WO2008076490A3 Histophilus somni antigens, compositions and methods of use
12/18/2008WO2008027772A3 Ultrafast immunoextraction/displacement assays
12/18/2008DE19509881B4 Ovoglycoprotein und dasselbe enthaltende Agens für chromatografische Aufspaltung Ovoglycoprotein and containing the same agent for chromatographic splitting
12/18/2008CA2840407A1 Compositions and methods for producing bioactive fusion proteins
12/17/2008EP2001899A1 Peptides against autoantibodies associated with glaucoma and use of these peptides
12/16/2008US7465787 Transforming microorganism and monitoring expression of heterologous proteins on cell surface; monitoring protein-protein interactions and identifying modulators for treating autoimmune and cell proliferative diseases
12/16/2008US7465786 Nucleotide sequences coding polypeptide for use in the treatment of tumor and cell proliferative disorders
12/16/2008US7465785 Polypeptide encoded by a nucleic acid over-expressed in melanoma
12/16/2008CA2254975C Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 107